Panel

Noticias Financieras

Google AdSenseNews Headernews_header
AI Agents Force a Rethink of How Supply Chains Run
pymntshace 15h

AI Agents Force a Rethink of How Supply Chains Run

One of the underplayed areas of The Prompt Economy is the supply chain. But new developments around procurement and logistics have brought agentic AI to the fore in this area with a promise that bottlenecks in the last mile can be smoothed by this technology. Case in point: Agentic AI is making progress in [...]The post AI Agents Force a Rethink of How Supply Chains Run appeared first on PYMNTS.com.

#ECONOMY
ING: Turning AI Pilots Into Production
ffnewshace 15h

ING: Turning AI Pilots Into Production

In this conversation, Marco Li Mandri of ING offers a concrete, execution-focused view of what [...]The post ING: Turning AI Pilots Into Production appeared first on FF News | Fintech Finance.

#TECH
China Orders Banks to Cut U.S. Treasury Holdings: Is This Bullish for Bitcoin and Crypto?
coinpediahace 15h

China Orders Banks to Cut U.S. Treasury Holdings: Is This Bullish for Bitcoin and Crypto?

The post China Orders Banks to Cut U.S. Treasury Holdings: Is This Bullish for Bitcoin and Crypto? appeared first on Coinpedia Fintech NewsChina has ordered major banks to reduce their U.S. Treasury holdings, signaling a major shift in global finance. The move reflects rising concerns over U.S. debt risks and market volatility Experts believe that this decision could create new opportunities for Bitcoin and the overall crypto market. China Orders Banks to Reduce U.S. Bond Exposure Reports ...

#CRYPTO#COMMODITIES
India can emerge as biologics hub with right execution, says Wockhardt Chairman
cnbctv18hace 15h

India can emerge as biologics hub with right execution, says Wockhardt Chairman

Habil F Khorakiwala, Founder and Chairman of the Wockhardt Group, said a key growth driver for the company is its new antibiotic candidate, Zaynich. He said Wockhardt is preparing to launch the drug in the US largely on its own, rather than tying up with a larger pharmaceutical company, as it sees independent commercialisation as a logical next step after successfully developing the drug through its in-house research capabilities.

#STOCKS
Google AdSenseNews Footernews_footer